Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVALUATION OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) IN CURATIVE TREATMENT OF LOCALIZED PROSTATE CANCER AT LOW OR INTERMEDIATE RISK AND IN TREATMENT OF RECURRENCE AFTER RADIOTHERAPY (FORFAIT INNOVATION ART L165-1-1 Social Security Code)

NCT04307056 is registered in ClinicalTrials.gov with Association Francaise d'Urologie as lead sponsor.

NCT NCT04307056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVALUATION OF HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) IN CURATIVE TREATMENT OF LOCALIZED PROSTATE CANCER AT LOW OR INTERMEDIATE RISK AND IN TREATMENT OF RECURRENCE AFTER RADIOTHERAPY (FORFAIT INNOVATION ART L165-1-1 Social Security Code)
Lead sponsor
Association Francaise d'Urologie
Phase
Not applicable
Overall status
Completed
Start date
March 23, 2015
Completion date
August 24, 2022
Enrollment
3,862 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, ultrasound therapy